Other soluble mediators have been reported as biomarkers of COPD severity, such as a higher serum concentration of pulmonary and activation regulated chemokine (PARC or known as CCL18) in COPD patients compared to smoker or nonsmoker healthy controls [98]. The gene discussed is CCL18; the disease is chronic obstructive pulmonary disease.